SIA
GMAB icon

Schechter Investment Advisors’s Genmab GMAB Stock Holding History

Schechter Investment Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,289
Closed -$338K – 666
2024
Q1 		$338K Buy
11,289
+3,576
+46% +$105K 0.03% 473
2023
Q4 		$246K Sell
7,713
-5,994
-44% -$188K 0.02% 507
2023
Q3 		$483K Buy
13,707
+6,466
+89% +$246K 0.05% 349
2023
Q2 		$275K Buy
7,241
+94
+1% +$3.75K 0.02% 505
2023
Q1 		$270K Sell
7,147
-82
-1% -$3.15K 0.03% 545
2022
Q4 		$306K Sell
7,229
-937
-11% -$38.6K 0.03% 625
2022
Q3 		$262K Buy
8,166
+1,381
+20% +$48.5K 0.03% 749
2022
Q2 		$220K Sell
6,785
-874
-11% -$28.3K 0.02% 816
2022
Q1 		$277K Sell
7,659
-544
-7% -$18.7K 0.03% 732
2021
Q4 		$324K Buy
+8,203
New +$342K 0.03% 652

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schechter Investment Advisors's GMAB Position: Q2 2024 in Review

Schechter Investment Advisors sold out of Genmab (GMAB) in Q2 2024, closing a stake of 11,289 shares — an estimated $338K sold.

Schechter Investment Advisors first reported a position in GMAB in Q4 2021 and held it in 10 quarters. The position peaked at $483K in Q3 2023. 219 funds tracked by Wall St. Rank hold GMAB as of Q2 2024.

  • Schechter Investment Advisors reported no remaining Genmab position as of Q2 2024 after selling out during the quarter.
  • Schechter Investment Advisors sold 11,289 Genmab shares in Q2 2024, an estimated $338K.
  • Schechter Investment Advisors first reported a position in Genmab in Q4 2021 and held it in 10 quarters.
  • Schechter Investment Advisors's Genmab position peaked at $483K in Q3 2023.
  • 219 funds tracked by Wall St. Rank held Genmab as of Q2 2024.

Based on Schechter Investment Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.